Popular Articles

First Human Receives Cardiac Stem Cells In Clinical Trial To Heal Damage Caused By Heart Attacks
Doctors at the Cedars-Sinai Heart Institute announced today the completion of the first procedure in which a patient"s own heart tissue was used to grow specialized heart stem cells that were then injected back into the patient"s heart in an effort to repair and re-grow healthy muscle in a heart that had been injured by a heart attack. The minimally-invasive procedure was completed on the first patient on Friday, June 26.

Calorie-Burning 'Brown Fat' Found In Adults, Especially Women
Keeping your baby fat turns out to be a good thing, as long as it is "brown fat"- the kind that burns calories, according to a study that found adults have much more of this type of fat than previously thought. The results, which suggest a new way to treat obesity, were presented at The Endocrine Society"s 91st Annual Meeting in Washington, D.C.
News of the day
Oregon's First Confirmed Death From Novel H1N1 (swine) Influenza Reported In Marion County, USA
A Marion County woman with confirmed novel H1N1 (swine) influenza died on Sunday. "We are saddened by this death, and our hearts go out to the family," said Dr. Karen Landers, health officer for Marion County. "It"s an unfortunate reminder of the seriousness of flu."
Nutrition

Scientists Find Faster, Cheaper Way To Identify Cancer Causing Genes

Researchers at the University of Virginia Health System have found a new way to study how genes function in living organisms, and their approach could substantially cut the time and costs that drug makers spend in searching for potential targets for new cancer therapies. "A big problem in biology is that there are many thousands of genes. Testing the function of any one of them in a living organism, such as a mouse, has traditionally been slow and very expensive," notes Ian Macara, PhD, professor of microbiology at UVA"s School of Medicine and co-author of a study published in the June 15 issue of Genes & Development. "The new technology is hundreds of times cheaper and many times faster than traditional approaches. While we used it to study the function of a specific breast-developing gene, our method can be replicated in screening for genes that can suppress tumors or cause cancer." In Genes & Development, UVA researchers describe how they isolated mammary gland stem cells from mice and then infected the cells with a virus that enabled the scientists to manipulate a particular gene and cause it to glow green. When transplanted in mice that had undergone mastectomies, the altered stem cells regenerated entire new breasts within a few months. Because the target gene glowed green, researchers could monitor its role in the development of the new breast. The UVA study tracked Par3, a polarity protein that controls how cells acquire particular shapes, so that they have a top and a bottom. "When we shut off this gene, the stem cells had problems differentiating into the right types of cells, causing problems with mammary development. Interestingly, the glands that formed looked very much like early, pre-malignant tumor growths," explains Luke Martin McCaffrey, PhD, a post-doctoral fellow in the Center for Cell Signaling at UVA and study co-author. Par3"s function is of interest to cancer researchers and drug developers because the protein helps regulate the shape of epithelial cells, which can become malignant when deformed. Over 90 percent of solid tumors arise from epithelial cells, and early dissemination of transformed cells to distant sites is the leading cause of death from cancer. University of Virginia Health System


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):